22. Rants about lengthy and complex sales aids
Sick of long e-sales aids that contain too much info about clinical trials? Is this less or more of a compliance risk? Listen as we suggest practical solutions.
9 Marras 20234min
21. Myths about the PMCPA, the ABPI Code and self-regulation
Rina & Jean discuss some myths (please let us know if you think of others). We will be putting these to Alex Fell (Director, PMCPA) at our Annual Conference.
2 Marras 20233min
20. Commercial package deals and alleged inducements to prescribe
Rina & Jean cover the recent ruling in Case AUTH/3701/10/22 (Astellas v Janssen) and discuss pharma providing nurse support, patient support programmes and inducements to individuals.
26 Loka 20232min
19. Comms fit for the public - learn from Virginia Chachati, Pharmacist & Clinical Content Creator
When it comes to pharma materials, we know our intent vs the impression to readers can be different! This can lead to: not getting the right message across difficulty getting engagement from the r...
19 Loka 202314min
18. Disease Awareness - Part 1
The topic of Disease Awareness always produces a lot of questions. We tackle some of them in this podcast. The case mentioned is case AUTH/3652/5/22.
12 Loka 20235min
17. Cocktails in a 5-star hotel
Rina & Jean chat about how the venue and signage for UK pharma meetings can give a misleading impression. Case discussed is Case AUTH/3644/5/22 & AUTH/3694/10/22.
5 Loka 20236min
16. When and how to use patient case studies
Patient case studies can be used really well in a variety of ways by different functions within pharma. Case mentioned is Case AUTH/3503/4/21. Further information in this article: https://globalforum...
28 Syys 20236min
14. Engaging patients to provide a service
Who, why, when and how should UK pharma compliantly engage patients to provide a range of services? We provide clarity in just a few minutes.
21 Syys 20236min
